Biological systems are characterized by the dynamic interplay of their components, and to understand how individual parts act together it is crucial to know the composition of a system and how it changes over time. The protein components are of prime interest as they provide structure and carry out many functions in the cell. The transcriptome has been much used as a proxy to infer changes in protein expression, as techniques for measuring global RNA levels preceded those for measuring the proteome. However, when the levels of an mRNA and its corresponding protein are systematically compared, many differences in their abundance emerge, resulting in poor quantitative correlation overall between transcriptome and proteome \[[@B1]-[@B3]\]. Ways of measuring protein levels directly are therefore highly desirable, and breakthroughs in mass spectrometry (MS)-based proteomics are starting to enable this on a global scale.

In experiments recently published in *Nature*, Ruedi Aebersold and colleagues (Malmström *et al*. \[[@B4]\]) combined MS-based measurements of protein abundance in the bacterial pathogen *Leptospira interrogans*, the agent of Weil\'s disease, with imaging by cryo-electron tomography (CET) of distinct structures of known protein composition, such as the flagellar motor (in which the precise number and type of the protein subunits can be counted). The CET imaging provided a way of confirming the MS protein-quantitation data. The protein-abundance measurements then enabled the effect of the antibiotic ciprofloxacin on a large fraction of the *Leptospira*proteome to be determined. In this article we describe some of the recent developments in MS-based proteomics that enable such experiments, focusing on quantitative techniques that will eventually allow a complete inventory of cellular proteins. The goal for proteomics is the measurement of the absolute and relative abundances of proteins at high accuracy and with minimal effort. But currently this means a compromise between depth of analysis and measurement time.

Identifying proteins by mass spectrometry
=========================================

Intact proteins are difficult to identify by MS because their sequence cannot be obtained by fragmentation and so MS-based proteomics relies on analysis of peptides obtained by proteinase digestion of the sample. By analogy with genome-sequencing methods, this approach has been called \'shotgun\' proteomics. The resulting peptide mixtures are dauntingly complex and are fractionated before submitting them to MS. Several recent studies, including the determination of the yeast and *Leptospira*proteomes \[[@B2],[@B4]\], used isoelectric focusing in so-called OFF-gels \[[@B5],[@B6]\] as a first separation step. Following this initial fractionation, peptides are separated by liquid chromatography (LC) most commonly directly coupled to electrospray ionization of peptides (ESI) or less frequently to matrix-assisted laser desorption ionization (MALDI) to produce ions for MS.

In the next step, mass-to-charge (*m*/*z*) values of peptides and their ion intensities are determined by MS (MS^1^or \'parent ion\' spectra). To reliably identify peptides, the (typically) 5 to 20 most abundant peptides are selected for further fragmentation, resulting in a sequence-characteristic spectrum (MS^2^or fragmentation spectrum) for each peptide that is used to search databases to identify the peptide (Figure [1a](#F1){ref-type="fig"}). In the determination of the *Leptospira*proteome, Malmström *et al*. \[[@B4]\] collected more than 415,000 MS^2^spectra that could be assigned to more than 18,000 unique peptides, leading to the identification of 2,221 proteins (61% of the predicted open reading frames). To analyze the complex peptide mixtures typical of proteomics very high mass resolution is required. Otherwise, MS spectra from different peptides overlap, making peptide identification and quantification potentially inaccurate and unreliable. Precision instruments, in particular orbital frequency resonance ion traps such as the Orbitrap \[[@B7]\], are therefore most widely used for proteomics.

![Quantitative MS-based proteomics. **(a)**Analysis of complex peptide mixtures by LC-MS^2^. Peptide mixtures are resolved by liquid chromatography, ionized through electrospray and resolved by MS^1^. Selected peptides are fragmented by collision with an inert gas and the resulting MS^2^spectra are recorded. **(b)**Quantitative proteomics strategies. In the SILAC technique, isotope-labeled peptide intensities (I) are compared in the MS^1^spectra. For \'label-free\' quantitation, intensities of peptides are compared between different runs. Alternatively, standard peptides are spiked into the mixture to yield calibration for absolute peptide abundances. *R*refers to the ratio between either heavy and light peptides (SILAC panel) or ion intensities between different runs (label-free quantitation).](gb-2009-10-10-240-1){#F1}

Methods for comparative quantitative proteomics
===============================================

A common goal in proteomics is the accurate quantification and comparison of the proteomes of cells in different physiological or developmental states. For *Leptospira*, the interesting question addressed by Malmström *et al*. \[[@B4]\] is how the proteome reacts to addition of an antibiotic. They took the approach of quantifying protein abundance directly using a label-free method, which we shall discuss later. Another approach would have been to derivatize the peptides from different conditions with isobaric labels that yield different, indicative, small molecules after fragmentation, a technique called isobaric tag for relative and absolute quantitation (iTRAQ) \[[@B8]\]. After fragmentation these derivatives yield distinctive small molecules indicative of the peptide. In such an experiment, the relative abundance of these indicators is used to quantify the relative abundance of the different peptides (and thus proteins) in the sample.

Metabolic labeling of proteins yields similar information, but avoids complications of *in vitro*coupling such as incomplete reactions. Samples are labeled *in vivo*with amino acids (lysine and arginine) labeled with heavy non-radioactive isotopes such as ^13^C or ^15^N, and compared with samples containing unlabeled amino acids, a technique called stable isotope labeling of cells in culture (SILAC) \[[@B9]\]. Peptides are then generated by digesting with proteinases (for example, trypsin) that cut specifically after labeled amino acids, thereby ensuring that each peptide contains at least one labeled amino acid. This results in a distinct shift in MS spectra between heavy and light peptides. The intensity ratio between peaks in a SILAC pair indicates the abundance ratio of proteins from which the peptides were derived (Figure [1b](#F1){ref-type="fig"}).

For more accurate measurements, multiple peptides from a protein are typically averaged and this analysis is now completely automated \[[@B10]\]. Because of the high resolving power of Orbitrap mass spectrometers, this methodology can be applied to very complex mixtures and closely spaced peaks can be well resolved. Together with only one previous fractionation step - isoelectric focusing - this experimental setup was used for the first quantitation of a eukaryotic proteome, that of *Saccharomyces cerevisiae*, in the haploid and diploid phases of the life cycle (4,399 proteins were identified and 4,033 quantitated from 1,788,451 SILAC pair peptides \[[@B2]\]). If the abundances of at least some proteins are known, as was the case in yeast, they can be used to calibrate the MS data and yield absolute protein measurements. Advantages of this approach include very accurate quantitation and the fact that no previous knowledge of proteins that change in abundance is required. This is in contrast to the classical protein-detection methods, for example, immunoblotting, where reagents are often limiting and a clear hypothesis about which protein(s) to measure is required. SILAC, pioneered by the Mann laboratory, is now widely used for protein analyses in yeast, flies and even mice \[[@B1],[@B2],[@B11],[@B12]\].

Label-free approaches
=====================

A limitation of SILAC experiments is that labeling is necessary but is not always possible - for example in human samples. One option is to compare SILAC-labeled reference extracts or recombinant proteins against samples of interest \[[@B13]\]. Alternatively, it may be desirable to find means of reliably quantifying protein abundance directly, an approach taken by Malmström *et al*. \[[@B4]\] for the characterization of *Leptospira*and its reaction to ciprofloxacin. Early methods of \'label-free\' quantification used the frequency of peptide selection for fragmentation as a measure of their abundance - termed \'spectral counting\' \[[@B14],[@B15]\]. Because that technique uses an indirect measurement for peptide abundance and only works reliably for proteins with many available peptides, alternatives have been developed. Specifically, peptide-ion intensities in the parent MS^1^spectrum are used to quantify peptide abundances. For this method, reproducible identification of the same peptides in different LC-MS runs is crucial (Figure [1b](#F1){ref-type="fig"}). This is achieved by high mass-accuracy measurements, and also by aligning different runs based on the LC retention time of matched peptides between them \[[@B16]\]. Although still somewhat less accurate than quantification methods relying on isotope labels, this methodology makes a variety of clinical and environmental samples accessible, such as cancer or other biopsies.

In a series of papers including the *Leptospira*study, the peptide-ion intensity method has been further developed to calibrate MS measurements and yield absolute quantifications \[[@B4],[@B6],[@B17],[@B18]\]. As standards for calibration, isotope-labeled reference peptides are spiked into samples. Comparison of the ion intensities of standards of known abundance and of the experimental peptides yields an absolute concentration for the latter (Figure [1b](#F1){ref-type="fig"}). In very complex mixtures, it can be difficult to detect such peptide pairs, but in principle, advances in instrumentation and development of analytic tools should eventually allow the measurement of most peptides in a mixture, including those spiked as a reference. In the meantime, targeted approaches such as selected reaction monitoring (SRM) are promising. In these experiments, a series of mass analyzers (for example, a triple quadrupole MS) \'filters\' only targeted peptides. In combination with isotope-labeled standards, the abundance of peptides is quantitated by comparison of parent ion pair intensities. As a result of effective filtering, SRM assays are performed very fast and can monitor a series of peptides. To obtain a calibration curve for the *Leptospira*proteome that can be extrapolated to determine the absolute abundances of all detected proteins, Malmström *et al*. \[[@B4]\] used 19 peptides to report on proteins ranging in abundance from 40 to 15,000 copies per cell. One appeal of this methodology is the rapid monitoring of a limited number of proteins, which would enable a comparison of abundance in many samples and the characterization of protein dynamics over time.

A potential problem with the peptide-ion intensity method is that parent ion scans are usually carried out using quadrupoles with high sensitivity and dynamic range but low mass accuracy, possibly leading to overlapping peaks and convolution of signals when analyzing complex mixtures. A remedy for this could be to acquire full high-resolution spectra by scanning MS and then select peptides for sequencing by an \'inclusion\' list. Satisfyingly, in the case of *Leptospira*\[[@B4]\], the quantitation obtained using an SRM-derived calibration curve agreed very well with the counting by CET of the subunits in prominent cellular structures such as the flagella and the flagellar motor, or of methyl-accepting proteins in individual cells. This work shows how MS-based proteomics combined with high-resolution CET can yield information on protein abundance and localization.

Having obtained accurate measurements of the levels of individual proteins, it is then possible to compare proteomes under different physiological conditions. In the case of *Leptospira*\[[@B4]\], the comparison showed that the bacterium reacts to ciprofloxacin by strongly inducing the expression of a number of proteins (whose existence was previously only predicted from the genome sequence), but maintains overall protein concentration. The upregulated proteins might include interesting targets for combination therapy and the experiment shows in principle how this technology can be used for an unbiased systems characterization.

Over the past decade, developments in MS-based proteomics have greatly accelerated. In particular, new instrumentation and automation of MS-spectra interpretation enables the quantification of essentially whole-organism proteomes in single experiments. Tools to calibrate measurements are already leading to the determination of absolute protein abundances and specialized methods can be used to target subsets of proteins. All together, these developments predict that MS-based proteomics will become a staple technique in systems biology.
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